Politics ❯ Government Policy ❯ Trade Policy ❯ Tariffs

Pharmaceutical Tariffs

White House Pauses Drug Tariffs as Pfizer Signs On to TrumpRx and MFN Pricing

Health policy analysts caution the announced steps may deliver budget savings more than lower pharmacy bills for typical patients.

U.S. Eases Pharma Tariff Threat as Pfizer Agrees to Price Cuts and $70 Billion U.S. Investment

White House Clinches Pfizer Pricing Deal Tied to Tariff Reprieve and $70 Billion U.S. Investment

U.S. Imposes 100% Tariffs on Branded Drug Imports as Trump Unveils TrumpRx and Secures Pfizer Price Cuts

White House Secures Pfizer Deal on Drug Prices With TrumpRx Discounts and $70 Billion U.S. Investment

Trump Announces 100% Tariff on Branded Drug Imports, With Carve-Out for Firms Building U.S. Plants

U.S. Tariffs Set for Oct. 1 as Mexico Seeks Preferential Treatment, China Opens Probe

White House Signals 15% Cap on Japan Drug Tariffs as Trump Announces 100% Pharma Duties

Trump Sets 100% Tariff on Branded Drug Imports From Oct. 1, With Exemptions for U.S. Plant Builders

U.S. Imposes 100% Tariff on Branded Drug Imports, With New Levies on Trucks and Furniture Starting Oct. 1

U.S. Backs Argentina With Reported $20 Billion as Milei Courts Provincial Allies

U.S.–India Trade Rift Deepens as 50% U.S. Tariffs Bite and Trump Claims ‘No‑Tariff’ Offer

Trump Administration’s Pharma Tariff Decision Remains Weeks Away

U.S. Rolls Out 15%–41% Reciprocal Tariffs, Average Rate Hits 20.1%

Trump Doubles Tariffs on Indian Goods to 50% Over Russian Oil Purchases

Argentina’s Economy Struggles Under Soaring Costs and Capital Market Exclusion

Trump Sends Envoy to Moscow, Threatens Tariffs on India Ahead of Ukraine Cease-Fire Deadline

Trump Gives Pharma Until September 29 to Match Lowest Global Drug Prices

US and EU Strike Preliminary Trade Deal Setting 15% Tariffs

Trump Issues 50-Day Ultimatum to Russia, Threatening 100% Secondary Tariffs